Pharmacist Discharge Medication Reconciliation Study

Sponsor

Alberta Health services (Other)

Overall Status

Completed

CT.gov ID

NCT01226589

Collaborator

(none)

Enrollment

Location

Duration (Months)

4.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Adverse drug events can occur commonly due to medication errors during the transition of care in a health care facility. Medication reconciliation is the process of comparing medications and providing an accurate medication list as a resource for prescribers, which is currently only being done upon inpatient admission at the CCI. The purpose of this study is to see if pharmacist medication reconciliation at discharge reduces unintentional medication discrepancies for inpatient discharges.

Condition or Disease	Intervention/Treatment	Phase
Medication Reconciliation	Procedure: MRS	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

50 participants

Allocation:

Randomized

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

The Impact of Pharmacist Discharge Medication Reconciliation on Unintentional Medication Discrepancies From Inpatient Discharges at the Alberta Cancer Board Cross Cancer Institute

Study Start Date :

Oct 1, 2007

Actual Study Completion Date :

Oct 1, 2008

Outcome Measures

Primary Outcome Measures

MRS Correlation with Treatment Response. [up to 1 year]
The percentage of patients with at least one unintentional medication discrepancy after discharge from the Cross Cancer Institute

Secondary Outcome Measures

Correlation with Tumor Stage [up to 1 year]
The amount of medication discrepancies after discharge that has the potential to cause moderate harm to severe harm.
The frequency of each type of unintentional medication discrepancies. []

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Cancer inpatients under the care of Dr. Follett or Dr. Candler
Cancer inpatients to be discharged from the CCI
Patients >18 years of age
Patients that are taking >1 medications or herbals total at home.

Exclusion Criteria:

Cancer inpatients that are considered radioactive or in "hot rooms" (ie. Selectron patients or patients receiving radiation treatment for thyroid)
Patients that do not remain in hospital >72 hours
Patients without a home phone number or equivalent contact number.
Language barrier (patients unable to speak or understand English).
Patients that are readmitted and already included into the study.